Pacific Biosciences of California Overview
Pacific Biosciences of California Target Price
Analysts' 12-month price predictions for PACB.
Share Price
$1.24
Average Target Price
$1.50
21% upside
21% upside1 analysts in the last 4 months
High: $1.5 | Low: $1.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-25 | BarclaysLuke Sergott | $1.5 | 21% upside |  |
| 2024-06-03 | JefferiesTycho Peterson | $4 | 222.6% upside | |
| 2024-05-13 | Morgan StanleyTejas Savant | $4 | 222.6% upside | |
| 2024-05-13 | Piper SandlerDavid Westenberg | $2 | 61.3% upside | |
| 2024-05-10 | BarclaysLuke Sergott | $2 | 61.3% upside | |
| 2024-04-18 | Goldman SachsMatthew Sykes | $2.5 | 101.6% upside | |
| 2024-04-16 | Canaccord GenuityKyle Mikson | $3.5 | 182.3% upside | |
| 2022-11-16 | Canaccord Genuity | $14 | 1029% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $7.5 | 504.8% upside | |
| 2022-05-15 | Piper SandlerDavid Westenberg | $6 | 383.9% upside | |
| 2022-01-12 | Piper SandlerDavid Westenberg | $20 | 1512.9% upside | |